Aurinia Pharmaceuticals AUPH Stock
8 USD
{{ price }}
-2.200493%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
1.09B USD
LOW - HIGH [24H]
7.99
-
8.28 USD
VOLUME [24H]
1.25M USD
{{ volume }}
P/E Ratio
200.00
Earnings per share
0.04 USD
Aurinia Pharmaceuticals Price Chart
Aurinia Pharmaceuticals AUPH Financial and Trading Overview
| Aurinia Pharmaceuticals stock price | 8 USD |
| Previous Close | 7.69 USD |
| Open | 7.68 USD |
| Bid | 6.53 USD x 100 |
| Ask | 8.78 USD x 100 |
| Day's Range | 7.6 - 7.75 USD |
| 52 Week Range | 4.71 - 10.67 USD |
| Volume | 983.68K USD |
| Avg. Volume | 1.41M USD |
| Market Cap | 1.11B USD |
| Beta (5Y Monthly) | 1.456 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.04 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.84 USD |
AUPH Valuation Measures
| Enterprise Value | 847.82M USD |
| Trailing P/E | N/A |
| Forward P/E | 14.333332 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.0290456 |
| Price/Book (mrq) | 2.855035 |
| Enterprise Value/Revenue | 3.847 |
| Enterprise Value/EBITDA | 1712.775 |
Trading Information
Aurinia Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.456 |
| 52-Week Change | -3.25% |
| S&P500 52-Week Change | 22.67% |
| 52 Week High | 10.67 USD |
| 52 Week Low | 4.71 USD |
| 50-Day Moving Average | 8.66 USD |
| 200-Day Moving Average | 6.63 USD |
AUPH Share Statistics
| Avg. Volume (3 month) | 1.41M USD |
| Avg. Daily Volume (10-Days) | 1.65M USD |
| Shares Outstanding | 143.18M |
| Float | 128.87M |
| Short Ratio | 4.09 |
| % Held by Insiders | 7.20% |
| % Held by Institutions | 42.14% |
| Shares Short | 5.79M |
| Short % of Float | 4.07% |
| Short % of Shares Outstanding | 4.04% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2023 |
| Most Recent Quarter (mrq) | September 30, 2024 |
| Next Fiscal Year End | December 31, 2024 |
Profitability
| Profit Margin | -10.23% |
| Operating Margin (ttm) | 17.33% |
| Gross Margin | 76.85% |
| EBITDA Margin | 0.22% |
Management Effectiveness
| Return on Assets (ttm) | -2.15% |
| Return on Equity (ttm) | -5.78% |
Income Statement
| Revenue (ttm) | 220.36M USD |
| Revenue Per Share (ttm) | 1.54 USD |
| Quarterly Revenue Growth (yoy) | 24.30% |
| Gross Profit (ttm) | 169.36M USD |
| EBITDA | 495K USD |
| Net Income Avi to Common (ttm) | -22552000 USD |
| Diluted EPS (ttm) | -0.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 348.24M USD |
| Total Cash Per Share (mrq) | 2.43 USD |
| Total Debt (mrq) | 87.85M USD |
| Total Debt/Equity (mrq) | 22.64 USD |
| Current Ratio (mrq) | 5.603 |
| Book Value Per Share (mrq) | 2.711 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 28.59M USD |
| Levered Free Cash Flow (ttm) | 38.91M USD |
Profile of Aurinia Pharmaceuticals
| Country | United States |
| State | AB |
| City | Edmonton |
| Address | 118 Avenue , 14315 |
| ZIP | T5L 4S6 |
| Phone | 250 744 2487 |
| Website | https://www.auriniapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 300 |
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.
Q&A For Aurinia Pharmaceuticals Stock
What is a current AUPH stock price?
Aurinia Pharmaceuticals AUPH stock price today per share is 8 USD.
How to purchase Aurinia Pharmaceuticals stock?
You can buy AUPH shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aurinia Pharmaceuticals?
The stock symbol or ticker of Aurinia Pharmaceuticals is AUPH.
Which industry does the Aurinia Pharmaceuticals company belong to?
The Aurinia Pharmaceuticals industry is Biotechnology.
How many shares does Aurinia Pharmaceuticals have in circulation?
The max supply of Aurinia Pharmaceuticals shares is 136.65M.
What is Aurinia Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Aurinia Pharmaceuticals PE Ratio is 200.00000000 now.
What was Aurinia Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Aurinia Pharmaceuticals EPS is 0.04 USD over the trailing 12 months.
Which sector does the Aurinia Pharmaceuticals company belong to?
The Aurinia Pharmaceuticals sector is Healthcare.
Aurinia Pharmaceuticals AUPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ Composite Total Return I XCMP | 21258.23 USD — |
-0.1
|
— — | 20967.6 USD — | 21382.13 USD — | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| NASDAQ Biotechnology NBI | 4184.77 USD — |
+1.29
|
— — | 4144.83 USD — | 4202.15 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 1854.61 USD — |
+0.81
|
— — | 1835.2 USD — | 1871.93 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4157.43 USD — |
+0.21
|
— — | 3927.42 USD — | 4157.43 USD — | — - | — — |
- {{ link.label }} {{link}}